Your browser doesn't support javascript.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors.
Pedersen, Ole Birger; Nissen, Janna; Dinh, Khoa Manh; Schwinn, Michael; Kaspersen, Kathrine Agergård; Boldsen, Jens Kjærgaard; Didriksen, Maria; Dowsett, Joseph; Sørensen, Erik; Thørner, Lise Wegner; Larsen, Margit Anita Hørup; Grum-Schwensen, Birgitte; Sækmose, Susanne; Paulsen, Isabella Worlewenut; Frisk, Nanna Lond Skov; Brodersen, Thorsten; Vestergaard, Lasse Skafte; Rostgaard, Klaus; Mølbak, Kåre; Skov, Robert Leo; Erikstrup, Christian; Ullum, Henrik; Hjalgrim, Henrik.
  • Pedersen OB; Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark.
  • Nissen J; Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.
  • Dinh KM; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Schwinn M; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
  • Kaspersen KA; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Boldsen JK; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
  • Didriksen M; Danish Big Data Centre for Environment and Health (BERTHA), Aarhus University, Roskilde, Denmark.
  • Dowsett J; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
  • Sørensen E; Danish Big Data Centre for Environment and Health (BERTHA), Aarhus University, Roskilde, Denmark.
  • Thørner LW; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Larsen MAH; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Grum-Schwensen B; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Sækmose S; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Paulsen IW; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Frisk NLS; Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark.
  • Brodersen T; Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark.
  • Vestergaard LS; Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark.
  • Rostgaard K; Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark.
  • Mølbak K; Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark.
  • Skov RL; Infection Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
  • Erikstrup C; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Ullum H; Infection Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
  • Hjalgrim H; Infection Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
Clin Infect Dis ; 73(9): e2962-e2969, 2021 11 02.
Article in English | MEDLINE | ID: covidwho-1501026
ABSTRACT

BACKGROUND:

Although the vast majority of individuals succumbing to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are elderly, infection fatality rate (IFR) estimates for the age group ≥70 years are still scarce. To this end, we assessed SARS-CoV-2 seroprevalence among retired blood donors and combined it with national coronavirus disease 2019 (COVID-19) survey data to provide reliable population-based IFR estimates for this age group.

METHODS:

We identified 60 926 retired blood donors aged ≥70 years in the rosters of 3 regionwide Danish blood banks and invited them to fill in a questionnaire on COVID-19-related symptoms and behaviors. Among 24 861 (40.8%) responders, we invited a random sample of 3200 individuals for blood testing. Overall, 1201 (37.5%) individuals were tested for SARS-CoV-2 antibodies (Wantai) and compared with 1110 active blood donors aged 17-69 years. Seroprevalence 95% confidence intervals (CIs) were adjusted for assay sensitivity and specificity.

RESULTS:

Among retired (aged ≥70 years) and active (aged 17-69 years) blood donors, adjusted seroprevalences were 1.4% (95% CI, .3-2.5%) and 2.5% (95% CI, 1.3-3.8%), respectively. Using available population data on COVID-19-related fatalities, IFRs for patients aged ≥70 years and for 17-69 years were estimated at 5.4% (95% CI, 2.7-6.4%) and .083% (95% CI, .054-.18%), respectively. Only 52.4% of SARS-CoV-2-seropositive retired blood donors reported having been sick since the start of the pandemic.

CONCLUSIONS:

COVID-19 IFR in the age group >69 years is estimated to be 65 times the IFR for people aged 18-69 years.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Randomized controlled trials Limits: Aged / Humans Country/Region as subject: Europa Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Randomized controlled trials Limits: Aged / Humans Country/Region as subject: Europa Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid